期刊文献+

糖尿病视网膜病变的治疗 被引量:8

下载PDF
导出
摘要 随着糖尿病发病率增高,糖尿病视网膜病变(diabetic retinopathy,DR)的发病率也日益增加,已成为发达国家致盲人数最多的眼病.既往糖尿病所引起的黄斑水肿(diabetic macular edema,DME)和增殖性糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)主要通过眼底激光进行治疗.近年来,在药物治疗方面也有令人鼓舞的进展.本文着重对这些不同的治疗方案及其疗效比较进行综述.
出处 《协和医学杂志》 2013年第2期181-184,共4页 Medical Journal of Peking Union Medical College Hospital
  • 相关文献

参考文献33

  • 1Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group [ J]. Arch Oph- thalmol, 1985, 103:1796-1806.
  • 2Diabetic Retinopathy Clinical Research Network. A random- ized trial comparing intravitreal triamcinol0ne acetonide and focal/grid photocoagulation for diabetic macular edema [ J ]. Ophthalmology, 2008, 115 : 1447-1459.
  • 3Shah AM, Bressler NM, Jampol LM. Does laser still have a role in the management of retinal vascular and neovascular diseases? [J]. Am J Ophthalmol, 2011, 152:332-339.
  • 4Cardillo JA, Melo LAS, Costa RA, et al. Comparison of in- travitreal versus posterior sub-tenon's capsule injection of tri- amcinolone acetonide for diffuse diabetic macular edema [ J]. Ophthalmology, 2005, 112 : 1557-1563.
  • 5Takata C, Messias A, Folgosa MS, et al. Intravitreal injec- tion versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema [J]. Retina, 2010, 30:562-569.
  • 6Bonini MA, Jorge R, Barbosa JC, et al. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for re- fractory diabetic macular edema: a randomized clinical trial [ J]. Invest Ophthalmol Vis Sci, 2005, 46:3845-3849.
  • 7Choi YJ, Oh IK, Oh JR, et al. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic mac- ular edema [ J]. Korean J Ophthalmol, 2006, 20:205-209.
  • 8Yalcinbayir O, Gelisken O, Kadedi B, et al. Intravitreal ver- sus sub-tenon posterior triamcinolone injection in bilateral dif- fuse diabetic macular edema [ J ]. Ophthalmologica, 2011, 225:222-227.
  • 9Qi HP, Bi S, Wei SQ, et al. Intravitreal versus subtenon tri- amcinolone acetonide injection for diabetic macular edema: a systematic review and Meta-analysis [ J ]. Curr Eye Res, 2012, 37 : 1136-1147.
  • 10Bandello F, Polito A, Pognuz DR, et al. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy [ J ]. Arch Ophthalmol, 2006, 124:643-650.

同被引文献85

  • 1崔建华.糖网宁治疗糖尿病视网膜病变的临床观察[J].天津中医药,2005,22(5):411-411. 被引量:2
  • 2张俊华,商洪才,高秀梅,王辉,项耀祖,曹红波,任明,戴国华,毛静远,张伯礼.复方丹参方制剂治疗稳定型心绞痛随机对照试验的系统评价[J].天津中医药,2007,24(3):195-200. 被引量:22
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4李凤呜.中华眼科学[M].北京:人民卫生出版社,1996:1249.
  • 5Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy, diagnosis is less than Ⅱ, Prevalence and risk of diabetic retinopathy when age at 30 years[J]. Archives of Ophthalmology, 1984, 102(4):520-526.
  • 6Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002 [J]. Bulletin of the World Health Organization, 2004, 82(11):844-851.
  • 7Wilkinson CP, Ferris III FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology, 2003, 110(9): 1677-1682.
  • 8许迅.糖尿病视网膜病变的早期防治[J].中华眼科杂志,2008,44(1):9-11. 被引量:40
  • 9Jiao W,Zhang RY,Chen RP,et al.Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population[J].BMC Public Health,2013,13(15):2681-2694.
  • 10Stitt AW,Noemi L,Medina RJ,et al.Advances in our understanding of diabetic retinopathy[J].Clinical Science,2013,125(1):1-17.

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部